Drug Profile
Research programme: influenza A virus H7N9 vaccine - Replikins
Alternative Names: H7N9 Replikin peptide vaccine; H7N9 Synthetic Replikins VaccineLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Replikins
- Class Influenza A vaccines; Influenza A virus H7N9 vaccines; Influenza virus vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Influenza A virus H7N9 subtype
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-A virus H7N9 subtype(Prevention) in USA (Intranasal, Aerosol)
- 18 Apr 2013 Research programme: influenza A virus H7N9 vaccine - Replikins is available for licensing as of 18 Apr 2013. www.replikins.com
- 09 Apr 2013 Early research in Influenza A virus infections (H7N9 subtype)(prevention) in USA (Intranasal)